Is telehealth allowed to prescribe Strattera?

Understanding Telehealth Access to Non-Stimulant ADHD Treatment

If you’re seeking treatment for ADHD but prefer the convenience of telehealth, you may be wondering about your medication options. While much attention focuses on stimulant medications like Adderall, non-stimulant alternatives like Strattera (atomoxetine) offer different benefits—and importantly, different regulatory considerations. This comprehensive guide examines the current telehealth landscape for obtaining non-stimulant ADHD medication in 2025.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

What is Strattera and Why Consider It?

Strattera (atomoxetine) is an FDA-approved medication for treating ADHD in children, adolescents, and adults. Unlike stimulant medications such as Adderall or Ritalin, Strattera is not a controlled substance, which means it doesn’t carry the same regulatory restrictions or abuse potential.

Key benefits of Strattera include:

• Not a controlled substance – No DEA scheduling means fewer prescribing restrictions
• Once-daily dosing – Can be taken in the morning or evening
• No risk of dependency – Not habit-forming like stimulant medications
• Continuous 24-hour symptom relief – Unlike stimulants which may wear off
• Fewer prescribing limitations – Can be prescribed with refills for 90 days or longer
• May be appropriate for patients with substance use concerns, anxiety, or tics

While stimulants are often first-line treatments due to their effectiveness, Strattera provides a valuable alternative for many patients, especially those who experience side effects from stimulants or have contraindications to their use.

Can You Get Strattera Prescribed via Telehealth?

Yes, you can obtain Strattera through telehealth services in all 50 states. Because Strattera is not a controlled substance, it’s not subject to the DEA’s Ryan Haight Act restrictions that normally limit telehealth prescribing of controlled medications.

‘Unlike stimulant medications, Strattera can be prescribed via telehealth without requiring an initial in-person visit under federal law,’ explains Dr. Sarah Johnson, a psychiatrist at Klarity Health. ‘This makes it much more accessible for patients who prefer virtual care or have difficulty accessing in-person providers.’

The Federal Regulatory Landscape

The key factors affecting telehealth ADHD treatment in 2025:

• Non-stimulant medications like Strattera: Not restricted by federal in-person requirements; can be prescribed via telehealth with standard medical evaluation
• Stimulant medications (Schedule II controlled): Currently allowed via telehealth under temporary DEA extensions through December 31, 2025
• Ryan Haight Act: The law requiring in-person exams before prescribing controlled substances is temporarily waived but could return in 2026 (for controlled substances only, not for Strattera)

If you’re specifically seeking Strattera treatment, the telehealth process is straightforward. A qualified healthcare provider licensed in your state can evaluate you through a video visit, assess your symptoms, make a diagnosis, and if appropriate, prescribe Strattera electronically to your pharmacy.

State-by-State Telehealth Rules for Non-Stimulant ADHD Medications

While federal law doesn’t restrict telehealth prescribing of non-controlled medications like Strattera, state regulations can vary. Here’s what you should know about some major states:

California

• Telehealth prescribing: Fully permitted for non-controlled medications
• No in-person requirement: Virtual evaluation satisfies the ‘good faith examination’ standard
• Provider types: Both physicians and nurse practitioners can prescribe Strattera via telehealth

New York

• Telehealth prescribing: Allowed for non-controlled medications like Strattera
• Note: NY implemented stricter rules in 2025 requiring in-person visits for controlled substances, but these don’t apply to Strattera
• Nurse practitioners: Can independently prescribe after meeting experience requirements

Florida

• Telehealth prescribing: Permitted for non-controlled medications
• No in-person requirement: Florida law allows virtual evaluation for Strattera
• Video requirement: Florida requires synchronous video (not just phone) for telehealth prescribing

Texas

• Telehealth prescribing: Allowed for mental health conditions including ADHD
• No in-person requirement: For non-controlled medications like Strattera
• Provider considerations: NPs in Texas require physician delegation to prescribe

Other States

Most states allow telehealth prescribing of non-controlled medications like Strattera without special restrictions. However, a few states have additional requirements:

• Alabama: Requires follow-up in-person visits within 12 months for ongoing telehealth care (with exemptions for mental health services)
• New Hampshire: Recently updated laws to allow telehealth prescribing with annual evaluations
• Georgia: Permits telehealth prescribing of non-controlled medications without special restrictions

The Telehealth ADHD Evaluation Process

When seeking Strattera treatment via telehealth, what should you expect? The process typically involves:

1. Initial consultation: Video appointment with a licensed provider who specializes in ADHD treatment
2. Comprehensive evaluation: Assessment of symptoms, medical history, and prior treatments
3. Diagnosis: Determination if you meet DSM-5 criteria for ADHD
4. Treatment planning: Discussion of medication options, including Strattera’s benefits and potential side effects
5. Prescription: If appropriate, electronic prescription sent to your pharmacy
6. Follow-up care: Regular check-ins to monitor effectiveness and adjust treatment as needed

‘At Klarity Health, we conduct thorough evaluations that match in-person standards of care,’ explains Dr. Johnson. ‘Our providers take time to understand each patient’s unique ADHD presentation before recommending any medication, including Strattera.’

What to Prepare for Your Telehealth ADHD Evaluation

To make your telehealth appointment productive:

• Document your symptoms: Note how ADHD affects your work, relationships, and daily functioning
• Gather medical records: Previous diagnoses, treatments, or evaluations related to ADHD
• List current medications: Including over-the-counter drugs and supplements
• Prepare questions: About treatment options, side effects, and follow-up care
• Check insurance coverage: Verify if your plan covers telehealth services and Strattera
• Ensure good connectivity: Find a quiet, private space with reliable internet for your video appointment

Comparing Stimulant vs. Non-Stimulant Telehealth Access

For context, here’s how telehealth access differs between Strattera and stimulant medications in 2025:

Who Can Prescribe Strattera via Telehealth?

The types of providers who can prescribe non-stimulant ADHD medications through telehealth include:

• Psychiatrists (MD/DO): Specialists in mental health with full prescribing authority
• Primary Care Physicians: Can diagnose and treat ADHD with medications
• Nurse Practitioners: Prescribing authority varies by state, but all states allow NPs to prescribe non-controlled medications like Strattera (either independently or under collaboration)
• Physician Assistants: Can prescribe under physician supervision in all states

‘At Klarity Health, we match patients with providers who specialize in ADHD treatment and have extensive experience with both stimulant and non-stimulant medications,’ notes Dr. Johnson. ‘This ensures patients receive expert care tailored to their specific needs.’

Insurance Coverage and Cost Considerations

When seeking Strattera through telehealth, consider these financial aspects:

• Insurance coverage: Most major insurance plans cover both telehealth ADHD evaluations and Strattera prescriptions
• Prior authorization: Some plans require prior authorization for Strattera
• Generic availability: Atomoxetine (

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment